Company: CDT
Filing Date: 2025-08-12
Form Type: 424B3
Source: 0001641172-25-023191
Chunk: 15

Company: CDT Equity Inc.
Filing Date: 2025-08-12
Form: 424B3
Chunk 15
---
 writing prospectus that we may authorize for use in connection with this offering completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in the foregoing documents by these cautionary statements.

| 11 |

<div align='center'>USE OF PROCEEDS</div>

The Common Stock to be offered and sold using this prospectus will be offered and sold by the Selling Stockholders named in this prospectus. Accordingly, we will not receive any proceeds from any sale or disposition of shares of Common Stock held by the Selling Stockholders pursuant to this prospectus.

<div align='center'>SELLING STOCKHOLDERS</div>

This prospectus covers the resale or other disposition by the Selling Stockholders identified in the table below of up to an aggregate 255,285 shares of our Common Stock issued pursuant to the Joint Development Agreement, Consulting Agreement, and the issuance to E3 Fund SP. The Selling Stockholders acquired their securities in the transactions described above under the heading “ Joint Development Agreement” and “Harold Eytan Consulting Agreement”, and “ E3 Fund SP”.

The table below sets forth, as of August 6, 2025, the following information regarding the Selling Stockholders:

| ● | the                                                                                                                                     
 name of the Selling Stockholders;                                                                                                       |
| ● | the                                                                                                                                     
 number of shares of Common Stock owned by the Selling Stockholders prior to this offering;                                              |
| ● | the                                                                                                                                     
 number of shares of Common Stock to be offered by the Selling Stockholders in this offering;                                            |
| ● | the                                                                                                                                     
 number of shares of Common Stock to be owned by the Selling Stockholders assuming the sale of all of the shares of Common Stock covered 
 by this prospectus; and                                                                                                                 |
| ● | the                                                                                                                                     
 percentage of our issued and outstanding shares of Common Stock to be owned by Selling Stockholders assuming the sale of all of the     
 shares of Common Stock covered by this prospectus based on the number of shares of Common Stock issued and outstanding as of August     
 6, 2025.                                                                                                                                |

Except as described above, the number of shares of Common Stock beneficially owned by the Selling Stockholders has been determined in accordance with Rule 13d-3 under the Exchange Act and includes, for such purpose, shares of Common Stock that the Selling Stockholder has the right to acquire within 60 days of August 6, 2025.

All information with respect to the Common Stock ownership of the Selling